<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-08-30" modified="2017-11-22" version="120">
<accession>Q695T7</accession>
<accession>A8K446</accession>
<name>S6A19_HUMAN</name>
<protein>
<recommendedName>
<fullName>Sodium-dependent neutral amino acid transporter B(0)AT1</fullName>
</recommendedName>
<alternativeName>
<fullName>Solute carrier family 6 member 19</fullName>
</alternativeName>
<alternativeName>
<fullName>System B(0) neutral amino acid transporter AT1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">SLC6A19</name>
<name type="synonym">B0AT1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="999" last="1002">
<title>Mutations in SLC6A19, encoding B(0)AT1, cause Hartnup disorder.</title>
<authorList>
<person name="Kleta R."/>
<person name="Romeo E."/>
<person name="Ristic Z."/>
<person name="Ohura T."/>
<person name="Stuart C."/>
<person name="Arcos-Burgos M."/>
<person name="Dave M.H."/>
<person name="Wagner C.A."/>
<person name="Camargo S.R.M."/>
<person name="Inoue S."/>
<person name="Matsuura N."/>
<person name="Helip-Wooley A."/>
<person name="Bockenhauer D."/>
<person name="Warth R."/>
<person name="Bernardini I."/>
<person name="Visser G."/>
<person name="Eggermann T."/>
<person name="Lee P."/>
<person name="Chairoungdua A."/>
<person name="Jutabha P."/>
<person name="Babu E."/>
<person name="Nilwarangkoon S."/>
<person name="Anzai N."/>
<person name="Kanai Y."/>
<person name="Verrey F."/>
<person name="Gahl W.A."/>
<person name="Koizumi A."/>
</authorList>
<dbReference type="PubMed" id="15286787"/>
<dbReference type="DOI" id="10.1038/ng1405"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANT HND CYS-57</scope>
<scope>CHARACTERIZATION OF VARIANT HND CYS-57</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="1003" last="1007">
<title>Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19.</title>
<authorList>
<person name="Seow H.F."/>
<person name="Broeer S."/>
<person name="Broeer A."/>
<person name="Bailey C.G."/>
<person name="Potter S.J."/>
<person name="Cavanaugh J.A."/>
<person name="Rasko J.E.J."/>
</authorList>
<dbReference type="PubMed" id="15286788"/>
<dbReference type="DOI" id="10.1038/ng1406"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANTS HND ASN-173; PRO-242 AND LYS-501</scope>
<scope>CHARACTERIZATION OF VARIANTS HND ASN-173; PRO-242 AND LYS-501</scope>
<scope>VARIANTS GLN-240 AND ILE-252</scope>
<scope>CHARACTERIZATION OF VARIANTS GLN-240 AND ILE-252</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Kidney</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2008" name="J. Clin. Invest." volume="118" first="3881" last="3892">
<title>Iminoglycinuria and hyperglycinuria are discrete human phenotypes resulting from complex mutations in proline and glycine transporters.</title>
<authorList>
<person name="Broer S."/>
<person name="Bailey C.G."/>
<person name="Kowalczuk S."/>
<person name="Ng C."/>
<person name="Vanslambrouck J.M."/>
<person name="Rodgers H."/>
<person name="Auray-Blais C."/>
<person name="Cavanaugh J.A."/>
<person name="Broer A."/>
<person name="Rasko J.E."/>
</authorList>
<dbReference type="PubMed" id="19033659"/>
<dbReference type="DOI" id="10.1172/JCI36625"/>
</citation>
<scope>INVOLVEMENT IN HG AND IG</scope>
</reference>
<comment type="function">
<text evidence="4">Transporter that mediates resorption of neutral amino acids across the apical membrane of renal and intestinal epithelial cells. This uptake is sodium-dependent and chloride-independent.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="6">Membrane</location>
<topology evidence="6">Multi-pass membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="3 4">Robust expression in kidney and small intestine, with minimal expression in pancreas. Also expressed in stomach, liver, duodenum, ileocecum, colon and prostate. Not detected in testis, whole brain, cerebellum, fetal liver, spleen, skeletal muscle, uterus, heart or lung.</text>
</comment>
<comment type="disease" evidence="3 4">
<disease id="DI-01695">
<name>Hartnup disorder</name>
<acronym>HND</acronym>
<description>Autosomal recessive abnormality of renal and gastrointestinal neutral amino acid transport noted for its clinical variability. First described in 1956, HND is characterized by increases in the urinary and intestinal excretion of neutral amino acids. Individuals with typical Hartnup aminoaciduria may be asymptomatic, some develop a photosensitive pellagra-like rash, attacks of cerebellar ataxia and other neurological or psychiatric features. Although the definition of HND was originally based on clinical and biochemical abnormalities, its marked clinical heterogeneity has led to it being known as a disorder with a consistent pathognomonic neutral hyperaminoaciduria.</description>
<dbReference type="MIM" id="234500"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="5">
<disease id="DI-02939">
<name>Hyperglycinuria</name>
<acronym>HG</acronym>
<description>A condition characterized by excess of glycine in the urine. In some cases it is associated with renal colic and renal oxalate stones.</description>
<dbReference type="MIM" id="138500"/>
</disease>
<text>The disease may be caused by mutations affecting the gene represented in this entry. SLC6A19 deficiency combined with haploinsufficiency of SLC6A20 or partially inactivating mutations in SLC36A2, can be responsible for hyperglycinuria.</text>
</comment>
<comment type="disease" evidence="5">
<disease id="DI-02940">
<name>Iminoglycinuria</name>
<acronym>IG</acronym>
<description>A disorder of renal tubular reabsorption of glycine and imino acids (proline and hydroxyproline), marked by excessive levels of all three substances in the urine.</description>
<dbReference type="MIM" id="242600"/>
</disease>
<text>The disease may be caused by mutations affecting the gene represented in this entry. SLC6A19 deficiency combined with haploinsufficiency of SLC6A20 or partially inactivating mutations in SLC36A2, can be responsible for iminoglycinuria. Additional polymorphisms and mutations in SLC6A18 can contribute to the IG phenotype in some families.</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family. SLC6A19 subfamily.</text>
</comment>
<dbReference type="EMBL" id="AY596807">
<property type="protein sequence ID" value="AAT42127.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY591756">
<property type="protein sequence ID" value="AAT66171.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK290811">
<property type="protein sequence ID" value="BAF83500.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471102">
<property type="protein sequence ID" value="EAX08175.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS34130.1"/>
<dbReference type="RefSeq" id="NP_001003841.1">
<property type="nucleotide sequence ID" value="NM_001003841.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.481478"/>
<dbReference type="ProteinModelPortal" id="Q695T7"/>
<dbReference type="STRING" id="9606.ENSP00000305302"/>
<dbReference type="GuidetoPHARMACOLOGY" id="939"/>
<dbReference type="TCDB" id="2.A.22.6.3">
<property type="family name" value="the neurotransmitter:sodium symporter (nss) family"/>
</dbReference>
<dbReference type="iPTMnet" id="Q695T7"/>
<dbReference type="PhosphoSitePlus" id="Q695T7"/>
<dbReference type="BioMuta" id="SLC6A19"/>
<dbReference type="DMDM" id="73919285"/>
<dbReference type="PaxDb" id="Q695T7"/>
<dbReference type="PeptideAtlas" id="Q695T7"/>
<dbReference type="PRIDE" id="Q695T7"/>
<dbReference type="DNASU" id="340024"/>
<dbReference type="Ensembl" id="ENST00000304460">
<property type="protein sequence ID" value="ENSP00000305302"/>
<property type="gene ID" value="ENSG00000174358"/>
</dbReference>
<dbReference type="GeneID" id="340024"/>
<dbReference type="KEGG" id="hsa:340024"/>
<dbReference type="UCSC" id="uc003jbw.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="340024"/>
<dbReference type="DisGeNET" id="340024"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000174358.15"/>
<dbReference type="GeneCards" id="SLC6A19"/>
<dbReference type="HGNC" id="HGNC:27960">
<property type="gene designation" value="SLC6A19"/>
</dbReference>
<dbReference type="HPA" id="HPA037415"/>
<dbReference type="HPA" id="HPA043207"/>
<dbReference type="MalaCards" id="SLC6A19"/>
<dbReference type="MIM" id="138500">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="234500">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="242600">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="608893">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q695T7"/>
<dbReference type="OpenTargets" id="ENSG00000174358"/>
<dbReference type="Orphanet" id="2116">
<property type="disease" value="Hartnup disease"/>
</dbReference>
<dbReference type="Orphanet" id="42062">
<property type="disease" value="Iminoglycinuria"/>
</dbReference>
<dbReference type="PharmGKB" id="PA134968815"/>
<dbReference type="eggNOG" id="KOG3659">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0733">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000119044"/>
<dbReference type="HOGENOM" id="HOG000116406"/>
<dbReference type="HOVERGEN" id="HBG071421"/>
<dbReference type="InParanoid" id="Q695T7"/>
<dbReference type="KO" id="K05334"/>
<dbReference type="OMA" id="GYVEECA"/>
<dbReference type="OrthoDB" id="EOG091G08PX"/>
<dbReference type="PhylomeDB" id="Q695T7"/>
<dbReference type="TreeFam" id="TF343812"/>
<dbReference type="Reactome" id="R-HSA-352230">
<property type="pathway name" value="Amino acid transport across the plasma membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-442660">
<property type="pathway name" value="Na+/Cl- dependent neurotransmitter transporters"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5619044">
<property type="pathway name" value="Defective SLC6A19 causes Hartnup disorder (HND)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5659735">
<property type="pathway name" value="Defective SLC6A19 causes Hartnup disorder (HND)"/>
</dbReference>
<dbReference type="ChiTaRS" id="SLC6A19">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="SLC6A19"/>
<dbReference type="GenomeRNAi" id="340024"/>
<dbReference type="PRO" id="PR:Q695T7"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000174358"/>
<dbReference type="CleanEx" id="HS_SLC6A19"/>
<dbReference type="ExpressionAtlas" id="Q695T7">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q695T7">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0031526">
<property type="term" value="C:brush border membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0015171">
<property type="term" value="F:amino acid transmembrane transporter activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005328">
<property type="term" value="F:neurotransmitter:sodium symporter activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0015175">
<property type="term" value="F:neutral amino acid transmembrane transporter activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006865">
<property type="term" value="P:amino acid transport"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007584">
<property type="term" value="P:response to nutrient"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="InterPro" id="IPR000175">
<property type="entry name" value="Na/ntran_symport"/>
</dbReference>
<dbReference type="InterPro" id="IPR002438">
<property type="entry name" value="Na/ntran_symport_orphan"/>
</dbReference>
<dbReference type="InterPro" id="IPR037272">
<property type="entry name" value="SNS_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11616">
<property type="entry name" value="PTHR11616"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00209">
<property type="entry name" value="SNF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00176">
<property type="entry name" value="NANEUSMPORT"/>
</dbReference>
<dbReference type="PRINTS" id="PR01206">
<property type="entry name" value="ORPHTRNSPORT"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF161070">
<property type="entry name" value="SSF161070"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00610">
<property type="entry name" value="NA_NEUROTRAN_SYMP_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50267">
<property type="entry name" value="NA_NEUROTRAN_SYMP_3"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0029">Amino-acid transport</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0769">Symport</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0813">Transport</keyword>
<feature type="chain" description="Sodium-dependent neutral amino acid transporter B(0)AT1" id="PRO_0000214809">
<location>
<begin position="1"/>
<end position="634"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="1"/>
<end position="41"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=1" evidence="2">
<location>
<begin position="42"/>
<end position="62"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="63"/>
<end position="67"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=2" evidence="2">
<location>
<begin position="68"/>
<end position="88"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="89"/>
<end position="120"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=3" evidence="2">
<location>
<begin position="121"/>
<end position="141"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="142"/>
<end position="192"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=4" evidence="2">
<location>
<begin position="193"/>
<end position="213"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="214"/>
<end position="221"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=5" evidence="2">
<location>
<begin position="222"/>
<end position="242"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="243"/>
<end position="268"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=6" evidence="2">
<location>
<begin position="269"/>
<end position="289"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="290"/>
<end position="304"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=7" evidence="2">
<location>
<begin position="305"/>
<end position="325"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="326"/>
<end position="413"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=8" evidence="2">
<location>
<begin position="414"/>
<end position="434"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="435"/>
<end position="456"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=9" evidence="2">
<location>
<begin position="457"/>
<end position="477"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="478"/>
<end position="490"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=10" evidence="2">
<location>
<begin position="491"/>
<end position="511"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="512"/>
<end position="531"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=11" evidence="2">
<location>
<begin position="532"/>
<end position="552"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="2">
<location>
<begin position="553"/>
<end position="581"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=12" evidence="2">
<location>
<begin position="582"/>
<end position="602"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="2">
<location>
<begin position="603"/>
<end position="634"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="17"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="627"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="158"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="182"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="258"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="354"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2">
<location>
<position position="368"/>
</location>
</feature>
<feature type="sequence variant" description="In HND; abolishes transport activity; dbSNP:rs762989809." id="VAR_023314" evidence="3">
<original>R</original>
<variation>C</variation>
<location>
<position position="57"/>
</location>
</feature>
<feature type="sequence variant" description="In HND; population allele frequency among Europeans is 0.007; reduces transport activity by 50% but does not completely inactivates the transporter; dbSNP:rs121434346." id="VAR_023315" evidence="4">
<original>D</original>
<variation>N</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs758492838." id="VAR_023316" evidence="4">
<original>R</original>
<variation>Q</variation>
<location>
<position position="240"/>
</location>
</feature>
<feature type="sequence variant" description="In HND; completely abolishes the transport activity; dbSNP:rs200745023." id="VAR_023317" evidence="4">
<original>L</original>
<variation>P</variation>
<location>
<position position="242"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs7732589." id="VAR_023318" evidence="4">
<original>V</original>
<variation>I</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="sequence variant" description="In HND; completely abolishes the transport activity." id="VAR_023319" evidence="4">
<original>E</original>
<variation>K</variation>
<location>
<position position="501"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9D687"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000255"/>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15286787"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15286788"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19033659"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000305"/>
<sequence length="634" mass="71110" checksum="B85EFB02F9D53BB9" modified="2004-09-13" version="1">
MVRLVLPNPGLDARIPSLAELETIEQEEASSRPKWDNKAQYMLTCLGFCVGLGNVWRFPY
LCQSHGGGAFMIPFLILLVLEGIPLLYLEFAIGQRLRRGSLGVWSSIHPALKGLGLASML
TSFMVGLYYNTIISWIMWYLFNSFQEPLPWSDCPLNENQTGYVDECARSSPVDYFWYRET
LNISTSISDSGSIQWWMLLCLACAWSVLYMCTIRGIETTGKAVYITSTLPYVVLTIFLIR
GLTLKGATNGIVFLFTPNVTELAQPDTWLDAGAQVFFSFSLAFGGLISFSSYNSVHNNCE
KDSVIVSIINGFTSVYVAIVVYSVIGFRATQRYDDCFSTNILTLINGFDLPEGNVTQENF
VDMQQRCNASDPAAYAQLVFQTCDINAFLSEAVEGTGLAFIVFTEAITKMPLSPLWSVLF
FIMLFCLGLSSMFGNMEGVVVPLQDLRVIPPKWPKEVLTGLICLGTFLIGFIFTLNSGQY
WLSLLDSYAGSIPLLIIAFCEMFSVVYVYGVDRFNKDIEFMIGHKPNIFWQVTWRVVSPL
LMLIIFLFFFVVEVSQELTYSIWDPGYEEFPKSQKISYPNWVYVVVVIVAGVPSLTIPGY
AIYKLIRNHCQKPGDHQGLVSTLSTASMNGDLKY
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>